Back to News
Market Impact: 0.2

Nuwellis Submits FDA Application To Expand Aquadex Use In Pediatric Patients

Source: Nasdaq

Healthcare & BiotechRegulation & LegislationProduct Launches

Nuwellis announced that it submitted a 510(k) premarket notification to the FDA seeking to expand the indication for its Aquadex SmartFlow System. The available article text is truncated before specifying the proposed indication or any FDA decision, so the scope and timing of a potential expansion are not stated.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.10

Ticker Sentiment

NUWE0.45

More News

From AllMind Research

Browse all research